Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy | Zendy

Tarek A Yousry | Zendy; Eugene O. Major | Zendy; Caroline F. Ryschkewitsch | Zendy; Gary A. Fahle | Zendy; Steven H. Fischer | Zendy; Jean Hou | Zendy; Blanche Curfman | Zendy; Katherine Miszkiel | Zendy; Nicole MuellerLenke | Zendy; Esther Sánchez | Zendy; Frederik Barkhof | Zendy; ErnstWilhelm Radue | Zendy; Hans Rolf Jäger | Zendy; David B. Clifford | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy

Author(s) -

Tarek A Yousry,

Eugene O. Major,

Caroline F. Ryschkewitsch,

Gary A. Fahle,

Steven H. Fischer,

Jean Hou,

Blanche Curfman,

Katherine Miszkiel,

Nicole MuellerLenke,

Esther Sánchez,

Frederik Barkhof,

ErnstWilhelm Radue,

Hans Rolf Jäger,

David B. Clifford

Publication year - 2006

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa054693

Subject(s) - progressive multifocal leukoencephalopathy , natalizumab , medicine , jc virus , cerebrospinal fluid , multiple sclerosis , magnetic resonance imaging , clinical trial , radiology , immunology

Progressive multifocal leukoencephalopathy (PML) was reported to have developed in three patients treated with natalizumab. We conducted an evaluation to determine whether PML had developed in any other treated patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research